During the last few years, pathologists have assumed several important roles in the assessment of adenocarcinomas of the prostate. The establishment of postoperative serum prostate-specific antigen (PSA)
Jonathan I. Epstein, MD
Advertisement
Articles by Jonathan I. Epstein, MD
Advertisement
Latest Updated Articles
- Pathologic Evaluation of Prostatic Carcinoma: Critical Information for the Oncologist
Published: April 1st 1996 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
2
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
3
Novel TLR Coagonist Combo Shows Responses in Stage IV NSCLC
4
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
5
